Karnofsky Performance Status (KPS) is a well established pre-surgical prognostic factor for the survival of patients affected by Glioma Grade 4 (GG4) tumors, including astrocytoma IDH-mutant grade 4 and the astrocytoma IDH wild type. This evidence concerns the gene IDH2 and central nervous system cancer.